Exactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 per share. Merger with TPG Capital Now Valued at $737 Million.Read More
Exactech Announces Successful First Revision Knee Replacement Surgery with Truliant® InstrumentationRead More
Exactech Comments on Impact of Hurricanes Irma and Harvey. Adjusts Q3 Earnings Guidance and Announces Q3 Earnings CallRead More
Exactech’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)Read More
Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue; Q2 Net Income $4.8 Million; Diluted EPS $0.33Read More
